Where to buy
Where to buy Retatrutide in the UK
Retatrutide is an investigational triple agonist at the GLP-1, GIP, and glucagon receptors. Eli Lilly is in Phase 3 development. The compound is NOT a UK-licensed medicine. A subset of UK research-peptide retailers stock it as a research-tier vial. PeptideClear does not recommend buying research-tier vials of unlicensed weight-management compounds. Use a GPhC-regulated pharmacy with a GMC-registered prescriber for any licensed GLP-1 medication.
What it is
Retatrutide is an investigational triple agonist peptide. UK availability is research-tier only.
Caveats before buying
- · NOT UK-licensed. Phase 3 development by Eli Lilly.
- · PeptideClear does not recommend buying research-tier vials of unlicensed weight-management compounds.
- · For licensed weight-management medication, use a GPhC-regulated pharmacy with a GMC prescriber.
Filter by compound
Retatrutide prices across UK retailers
Snapshot 2026-05-20. Verify on retailer site.
No products catalogued for this compound yet. UK retailers may stock it under different naming. Browse the full UK retailer directory or contact us if you spot a listing we should add.
Frequently asked questions
When will Retatrutide be UK-licensed?
Eli Lilly has not announced UK licensing dates. Phase 3 trials are ongoing. MHRA review timing depends on trial completion and filing.
Should I buy research-tier Retatrutide?
Not a clinical recommendation. PeptideClear is editorial. Licensed GLP-1 routes go via UK prescribers.
PeptideClear does not sell, dispense, prescribe, or recommend Retatrutide for any specific person. This page is editorial commentary on the UK retail landscape, ranked by Certificate of Analysis Trust tier. Every research peptide on this page is sold under research-use-only framing.
Read our full methodology and how we are funded.
Ready to buy
Shop UK peptides, collagen and GLP-1 routes
Compare UK retailers, clinics and pharmacies across every PeptideClear category.